Related by context. All words. (Click for frequent words.) 73 Receives Orphan Drug Designation 72 Strengthens Position 71 Begins Shipment 71 Announces FDA Clearance 71 Initiates Clinical Trials 71 FDA Clears 71 Files IND 71 Announce License Agreement 70 Completes Patient Enrollment 70 Announces License Agreement 70 Sign Licensing Agreement 70 Initiates Enrollment 70 Completes Enrollment 69 Meets Primary Endpoint 69 Initiates Clinical Trial 69 Signs License Agreement 69 Signs Licensing Agreement 69 N.V. 69 * vwd BUSINESS WIRE 69 Initiates Phase II 69 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 68 Announces Licensing Agreement 68 Expand Relationship 68 Receives Approvable Letter 68 Gets FDA Clearance 68 Drug Candidate 68 Expanded Indication 68 Submits Application 67 Announce Collaboration Agreement 67 Develop Novel 67 Commercializes 67 Sign License Agreement 67 Initiates Phase III 67 Strengthens Leadership 67 Receives FDA Clearance 67 DGAP Ad hoc 67 Patent Issued 67 Announces Successful Completion 67 Announce Licensing Agreement 67 Submits NDA 67 Expands Portfolio 67 Unveils Latest 67 Develop Next Generation 66 Achieves Certification 66 Further Strengthens 66 Announces Initiation 66 Announcement acc 66 Files Patent Application 66 Expands Capacity 66 Novel Oral 66 Introduces Next Generation 66 Presents Positive 66 AUDIO PROVIDED BY 66 Reconfirms 66 Signs Merger Agreement 66 Granted Orphan Drug 66 Therapeutic Competitors Report 65 Transdermal Patch 65 Announces Favorable 65 Restructures Operations 65 Obtains License 65 Extends Collaboration 65 Settles Litigation 65 Extend Relationship 65 Successful Launch 65 Successfully Completes Phase 65 Announces Tentative Approval 65 Study Evaluating 65 Announce Collaboration 65 Announce Agreement 65 Single Dose 65 Strengthens Its 65 Drug Shows Promise 65 Jointly Develop 65 Completes Successful 65 News Unternehmensnachrichten 65 Expand Collaboration 65 ADDING MULTIMEDIA 65 Antitumor Activity 65 Extends Relationship 65 Plans Job Cuts 65 Establish Joint Venture 65 Outlines Strategy 65 BW CA 65 Successfully Completes 65 meldt van 65 Wins Approval 65 COMUNICADO DE 65 Achieves Milestone 65 Develops Innovative 65 Pooled Analysis 65 Awarded Patent 65 FDA APPROVES 65 Adjuvant Treatment 65 APA ots news 65 Obtains Approval 65 News Unternehmensnachrichten DGAP Adhoc 64 Enters Agreement 64 Net Loss Narrows 64 Second Quarter Profit Rises 64 Receives Tentative Approval 64 Launches Next Generation 64 Successfully Deploys 64 Inks Pact 64 Receives Favorable 64 Expands Relationship With 64 SWOT Analysis Aarkstore Enterprise 64 ATOS ORIGIN 64 Settles Patent Dispute 64 Refocuses 64 Finalizes Acquisition 64 Receives Patent 64 Secures Financing 64 Achieves Significant 64 Receives Clearance 64 Commences Phase 64 Licensing Pact 64 Files Patent 64 Submits IND 64 Introduces Enhanced 64 Settle Patent Litigation 64 * vwd PRN 64 Co. KgaA 64 Announces Sponsorship 64 IPSEN 64 Receives Orphan Drug 64 Unveils Groundbreaking 64 Announce Initiation 64 Renews Agreement 64 Announces Immediate Availability 64 Cuts Costs 64 3M Completes Acquisition 64 Licensing Deal 64 Significantly Increases 64 Announces Publication 64 DJ HUGIN NEWS 64 Combination REOLYSIN R 64 Acquire Stake 64 Announce Exclusive 64 Extend Collaboration 63 Shares Plummet 63 meldt 63 Patients Treated With 63 Terminates Contract 63 ots.CorporateNews 63 Completes Transaction 63 PRN FDA Approves 63 Unveils Innovative 63 Improved Survival 63 Acquires Majority Stake 63 Boosts Productivity 63 Receives SFDA Approval 63 Announce Joint Venture 63 Secures Contract 63 Achieves Primary Endpoint 63 Buys Majority Stake 63 Finalize Agreement 63 Announce Merger Agreement 63 Delivers Next Generation 63 Announces Intent 63 Unwraps 63 Miscellaneous #.#.# Release 63 Mutually Agree 63 Reduces Risk 63 Validates 63 Initiates Phase 63 Ink Deal 63 Completes Integration 63 Raises Stake 63 Posts 4Q 63 DE ATIVIDADE PALAVRA-CHAVE/EMPRESA 63 Signs Pact 63 Broadens Its 63 Continues Momentum 63 Reports Preclinical Data 63 Enters Strategic 63 Accelerates Growth 63 Inks MOU 63 Reinforces 63 Enters Into Strategic 63 Phase 2a Trial 63 First Patient Dosed 63 Signs Agreements 63 DJ DGAP IRE 63 Develop Innovative 63 Improves Efficiency 63 Expands Capabilities 63 Extends Reach 63 Quarterly Profit Rises 63 Sharpens Focus 63 Awarded Multi 63 Successfully Tested 63 Cholesterol Lowering Drug 63 Approve Merger 62 Acquire Controlling Interest 62 Announce Receipt 62 Veröffentlichung gemäß § 62 Achieves Record Sales 62 Successfully Tests 62 Stockholders Approve Merger 62 Settles Dispute 62 Completes Merger With 62 Merger Creates 62 Leadership Position 62 Unveils Newest 62 Launches Groundbreaking 62 Receives Approval 62 Effectively Treats 62 Achieves Highest 62 Board Authorizes 62 Extend Partnership 62 Confirms Commitment 62 Introduces Innovative 62 phenyl salicylate methylene blue 62 Host Webcast 62 Demonstrates Commitment 62 Jointly Announce 62 Successfully Launches 62 Successfully Completes Tender Offer 62 Quarter Results #.#.# 62 Collaborates With 62 Trial Evaluating 62 Establishes Strategic 62 hat heute 62 Awarded Patents 62 Posts Strong 62 Announces Presentation 62 Commercialize 62 ABLYNX 62 Previously Treated 62 Announces Voluntary Recall 62 Pharma Merck Serono 62 Explore Strategic Alternatives 62 Explores Strategic Alternatives 62 Successfully Closes 62 Completes Transition 62 Completes Tender Offer 62 Pivotal Trial 62 Settle Litigation 62 Planned Acquisition 62 Tezampanel 62 Buy Majority Stake 62 AG Veröffentlichung gemäß § 62 Submits Bid 62 Q2 Adj 62 Improves Outcomes 62 Releases Enhanced 62 Unveils Next Generation 62 Announce Expiration 62 Restructures 62 Net Loss Widens 62 Amends Agreement 62 Successful Completion 62 Wins Contract 62 Subsidiary Enters 62 Receives Approvals 62 Prolongs Survival 62 Extends Tender Offer 62 Reports Positive 62 Phase 2a Clinical Trial 62 Inks Distribution 62 benzoic acid hyoscyamine sulfate 62 Orally Active 62 DOXIL R 62 For Undisclosed Terms 62 Voluntarily Withdraw 62 Completes Reorganization 62 Secures Funding 62 TRADESHOW SOURCE 62 Officially Launches 62 Announces Divestiture 62 Shareholders Approve Merger Agreement 62 Anounces 62 Increases Productivity 62 PRODUCT SOURCE 62 Expands Scope 62 Begins Shipping 62 Formalizes 61 Announce Availability 61 Celebrates Successful 61 Medoxomil 61 HUGIN NEWS 61 Jumps Higher 61 Expands Offerings 61 B.V. 61 Extends Commitment 61 CONFERENCE CALLS SOURCE 61 Net Profit Drops 61 Inks Agreement 61 Boosts Stake 61 overname 61 Shareholders Approve Acquisition 61 Strengthens Commitment 61 Enters Into License Agreement 61 Oral Fingolimod 61 Announce Definitive Agreement 61 Announces Stockholder Approval 61 Shows Efficacy 61 Clears Path 61 Q1 Loss Widens 61 Pending Acquisition 61 Evaluate Strategic Alternatives 61 Myeloma Patients 61 Reaffirms Commitment 61 Receives Certification 61 & Sullivan Recognizes 61 Submits Response 61 Introduces Breakthrough 61 Accelerate Commercialization 61 Acquires Majority 61 Stimmrechte 61 Affirms Commitment 61 Takes Majority Stake 61 Status Bidding 61 Strikes Deal 61 Signs Reseller Agreement 61 PRN4 61 Complete Merger 61 Novartis Novo Nordisk 61 Introduces Revolutionary 61 Double Blind Placebo 61 CHEAP ONLINE PHARMACY LOW 61 Provides Guidance 61 COLLABORATION WITH 61 Submits Proposal 61 Signs Agreement 61 Q1 Adj 61 Unveils Expanded 61 Takes Delivery 61 Study Confirms 61 PAUL Minn.MN 61 AGREEMENTS SOURCE 61 Oral Cladribine 61 Posts Profit 61 Launches Unique 61 Provides Comprehensive 61 들이 61 Sells Stake 61 PALAVRA CHAVE RJ PALAVRA-CHAVE/RAMO 61 Reduces Costs 61 Settle Patent Dispute 61 Momentum Continues 61 Largest Ever 61 Enters Into Agreement 61 Protease Inhibitor 61 Closes Buyout 61 Concludes Acquisition 61 Multi Billion Dollar 61 Announces Rebranding 61 Forges Strategic 61 Mass.MA 61 1st Quarter Results 61 Brain Metastases 61 Discontinues 61 Gets Approval 61 Announces Early Termination 61 Successfully Complete 61 Packs Pumps 61 Inks Deal 61 Status Denied 61 Ink Pact 61 Stocks Gain Paced 61 Spins Off 61 Bazedoxifene 61 AG deutsch 61 Renews Partnership 61 Provides Update Regarding 61 G. Profiling 61 Shows Promise Against 61 hat heute bekannt gegeben 61 Q3 Loss Narrows 61 Joins Forces 61 Exercises Option 61 Announce Intention 61 Completes Purchase Of 61 Files Shelf Registration Statement 61 Shareholders Approve Merger 61 Celebrates Decade 61 Announce Merger 61 Persbericht 61 Showcases Innovative 61 WEBBOLT Petrochemicals 61 Expand Into 61 resultaten 61 이다 61 COMPLETES ACQUISITION OF 61 Product Innovations Introductions 61 TH STAFF WRITER 60 Acquire Majority Stake 60 Completes Expansion 60 Expands Relationship 60 Successfully Launched 60 DGAP DD 60 Renews Relationship 60 Slims Down 60 Unveils Breakthrough 60 Exec Says 60 Expands Deployment 60 Develops Novel 60 Furthers 60 MANAGEMENT CHANGES SOURCE 60 Manufacturer Selects 60 Fortifies 60 Terminates Agreement 60 Stockholders Approve Acquisition 60 PRN3 60 Announce Expanded 60 Sees Strong 60 Successfully Concludes 60 Regains Compliance 60 Launches Innovative 60 Jointly Launch 60 PROFILE CO 60 Inks Licensing Deal 60 Signs Distribution 60 Announces Job Cuts 60 Announces Organizational Changes 60 News Aktienkurs Preliminary 60 Attains 60 Authorizes Additional 60 Forms Strategic 60 Annouces 60 MultiVu Video Feed 60 Takes Stake 60 Recombinant Human 60 Takeda Kyowa Hakko Kirin 60 Shareholders Approve 60 Forges Ahead 60 EZTEC Empreendimentos e 60 Lowers Guidance 60 Phase 2b Trial 60 Announces Enhancements 60 Increases Stake 60 Lowers Risk 60 onderzoek 60 Acquires Controlling Interest 60 Q3 Loss Widens 60 euro adhoc Stimmrechte 60 Expands Commitment 60 Provide Comprehensive 60 3rd Quarter Results 60 Achieves Prestigious 60 Enters Joint Venture 60 Complicated Skin 60 Establishes Joint Venture 60 Revolutionizes 60 YORKNY 60 folgenden Meldung ist nicht 60 Sees Significant 60 Rebrands 60 Interferon Alpha 60 Launches Enhanced 60 TO AVOID PREGNANCY WHILE 60 HER2 Positive Breast Cancer 60 Completes Divestiture 60 Settles Dispute With 60 의 을 60 Buys Stake 60 Introduces Novel 60 Formally Launches 60 Enter Into 60 Inks License 60 Commence Phase 60 Announce Strategic 60 Wafer polifeprosan 60 Surpasses Expectations 60 Receives Notification 60 volgt de tekst 60 Acquire Assets 60 Inks Licensing Agreement 60 Unveils Upgraded 60 Extends Contract 60 R Saizen R 60 More Than Doubles 60 Successfully Completed 60 Harris Hitachi Leapfrog 60 Streamlines Operations 60 Peginterferon Alfa 2a 60 Previously Announced 60 Inks Deals 60 Announces Successful 60 Reaffirms FY# Outlook 60 Completes Installation 60 Closes Merger 60 nimmt 60 Receives Favorable Ruling 60 Award Recognises 60 Latest Addition 60 Trims Loss 60 Ranks Number 60 Enters Into Exclusive 60 Signs Purchase Agreement 60 Updates Guidance 60 Ovitrelle R Serostim 60 SYS INC 60 Multicenter Study 60 Posts Record 60 한다 60 Commences Operations 60 Pressemitteilung 60 Announce Settlement 60 verantwortlich 60 DGAP Stimmrechte 60 Doubles Capacity 59 Lanthanum Carbonate 59 Establishes Subsidiary 59 Expands Internationally 59 Sinks Lower 59 Awarded GSA Schedule 59 Acquires Stake 59 Acquires Controlling Stake 59 CHRIS VERMEULEN RIZLA SUZUKI 59 Concludes Successful 59 Strengthens Presence 59 Anti Tumor Activity 59 WpHG Abs 59 SHARE HOLDER 59 Announce Completion 59 Confirms Talks 59 Announces Definitive Agreement 59 Competition G.1 59 Q1 Profit Surges 59 Profit Triples 59 Quadruples 59 Autologous Stem Cell Transplantation 59 Product Segment Accumulators 59 Receives Order 59 Deliver Next Generation 59 MARKETING AGREEMENTS SOURCE 59 Ups Stake 59 Vitrasert R 59 bedrijf 59 Reduces Debt 59 Announce Launch 59 Maintains Strong 59 Expects Higher 59 & Sullivan Lauds 59 Achieves ISO #:# Certification [002] 59 Subsidiary Receives 59 DGAP PVR 59 Acquires Exclusive 59 Submits 59 Completes Merger 59 neemt 59 Nears Deal 59 AND ANNOUNCE 59 Produkten 59 Companies Mentioned * 59 Consummates 59 Resubmits 59 Commercialize Novel 59 Résultats 59 Remains Committed 59 Status Closed 59 INDUSTRY ASSESSMENTS 59 Q2 Profit Surges 59 Wins Coveted 59 SCHMIDT TH STAFF WRITER 59 Initiates Voluntary Recall 59 Obtains Exclusive License 59 Win Prestigious 59 Extends Maturity 59 Bosutinib 59 Buys Into 59 Re Affirms 59 verfügt über 59 Quartalszahlen 59 Net Profit Soars 59 Signs Framework Agreement 59 Significantly Expands 59 lexidronam injection 59 Boosts Profits 59 Delivers Strong 59 FINMECCANICA 59 Mg Uk 59 Innovative Approach 59 Node Positive 59 Inks Contract 59 Voluntarily Recalls 59 Marks Milestone 59 Acquire Privately Held 59 2mins #.#s 59 Completes Reverse Merger 59 Snaps Up 59 Presse économique 59 collaborazione con 59 Int J Obes Relat 59 vapreotide acetate 59 Inks Deal With 59 Is Well Tolerated 59 Issues Statement Regarding 59 Ihrem Passwort hier wenn 59 Signs MoU 59 Announces Intention 59 LORIS CAPIROSSI RIZLA SUZUKI 59 Files Registration Statement 59 Completes Acquisition 59 BAG# BAG# BAG# BAG# 59 Issues Guidance 59 Achieves ISO 59 Proudly Announces 59 INTERNATIONAL EUROPE INDUSTRY KEYWORD 59 Merge Creating 59 DETECTS POSSIBLE BEARISH INSIDE 59 Announces Preliminary 59 Receives Positive 59 Renews Contract 59 가 59 YOUR INVOICE 59 Announces Dismissal 59 Hsp# Inhibitor 59 EPS ESTIMATES FOR 59 Improves Customer 59 REPRONEX R menotropins 59 Q3 Profit Surges 59 Host Webinar 59 Enhances Capabilities 59 5 FU leucovorin 59 Makes Strides 59 SUPERVISORY BOARD 59 MorphoSys AG FSE MOR 59 Obtains Exclusive Rights 59 DJ EANS Adhoc 59 Unveils Enhanced 59 Completes Sale Of 59 1Q Loss Narrows 59 Demonstrates Potential 59 Earns Certification 59 Confirms Receipt 59 Repositions 59 Amplifies 59 LIFE SCIENCES 59 ODT metoclopramide HCl PEPCID 59 Strongly Supports 59 Unicredit reste à acheter 59 Continues Expansion 59 Announces Termination 59 Receives Coveted 59 Much Anticipated 59 #,# Prozent mehr Geld 59 annuncia 59 Stockholders Approve 58 Cancer Patients Treated 58 Shoulder Prosthesis 58 Realigns 58 Fuel Cell Powered 58 Positions Itself 58 Beteiligungsges 58 Raise Stake 58 Closes Acquisition Of 58 Speeds Up 58 #mg Tablets [002] 58 Seeks Approval 58 Announces Effective Date 58 Signs Contract 58 Nasopharyngeal Electrodes Needle Electrodes 58 Signs Exclusive 58 GERMANY Marketwire #/#/# 58 Acquires Remaining Interest 58 의 은 58 Statement Regarding 58 Dry Powder Inhalers 58 Announces Availability 58 Scoops Up 58 CALLS EARNINGS SOURCE 58 READ THE DEFINITIVE 58 Secures Patent 58 Phase IIa Clinical Trial 58 Hormone Refractory Prostate Cancer 58 abacavir sulfate lamivudine 58 FY# Loss Widens 58 Taglich Brothers Initiates Coverage 58 Refines 58 Inaugurates 58 Increases Ownership 58 Sixth Consecutive Year 58 Becomes Exclusive Distributor 58 CHANGES SOURCE 58 IN PATIENTS WITH 58 RECORDATI 58 Signs Deal 58 Makes Headway 58 Achieves Record 58 Inhaled Corticosteroids 58 Acacia Subsidiary 58 对 的 58 gemäß § 58 Becomes Exclusive 58 Expands Globally 58 Wins Prestigious 58 ® DS methenamine 58 solvents polyols 58 Reinforces Commitment 58 Q4 Profit Jumps 58 Accredits 58 Fifth Consecutive 58 J Am Coll 58 WestLB Ups 58 WINS STAGE 58 AG Veröffentlichung einer Mitteilung 58 Enters Into Definitive Agreement 58 Announces Positive 58 Das Unternehmen 58 Inhalation Aerosol 58 Signs Long Term 58 Receives Recognition 58 Cooperates 58 Pivotal Phase III 58 Discloses 58 lanceert 58 CybeRelease Decliners 58 Outperforms 58 Elderly Patients 58 AND THE IMPLICATIONS 58 bei einem 58 Completes Refinancing 58 Collaborates 58 Gains Momentum 58 Orthop Surg 58 Regains Compliance With 58 Parathyroid Hormone 58 MAJOR PLAYERS 58 Relaunches 58 COMPANY NEWS 58 Finalizes Sale 58 Provides Preliminary 58 Reorganizes 58 Announce Partnership 58 Awarded Contract 58 Awaits Approval 58 może być niezwłocznie przeredagowana 58 Raises Dividend 58 By JENNIFER LEARN 58 Sign Definitive Agreement 58 Euro Keywords 58 Subsidiary Acquires 58 Builds Momentum 58 Reaches Milestone 58 Completes Purchase 58 Makes Bid 58 Signs MOU 58 Milestone Reached 58 에 58 PRN2 58 Unveil Next Generation 58 PHOTO ADVISORY 58 SIGNS AGREEMENT WITH 58 Develops Next Generation 58 PRNewsFoto 58 Changes Name 58 SWOT Analysis www.companiesandmarkets.com adds 58 Continues Aggressive 58 Declares Quarterly Dividends 58 Efficacy Trial 58 CT Kontakt 58 Pledges Support 58 Attracting Bullish Investors 58 CHEAP ONLINE PHARMACY BEST 58 PEGylated anti 58 Enters Into Agreements 58 LEVEL OF EFFICIENCY IN 58 Celebrates Opening 58 英国 58 Postpones IPO 58 EANS Stimmrechte 58 Zorbtive TM 58 全球 58 Closes Sale 58 Leonhard Kurz 58 Investigational Treatment 58 研究 58 Receives Contract 58 Quarterly Report Announcement 58 weiteren 58 Solution Helps 58 Named Exclusive Distributor 58 Significant Milestone 58 overeenkomst 58 Announces Completion 58 Laboratory pH Electrodes 58 Clinical Outcome 58 Antitumor 58 Receives Regulatory 58 Naive Patients 58 Completes Buyout 58 Auto Parts Maker 58 #.#.# Meldung [001] 58 Awarded Prestigious 58 一种 的 58 Expands Presence 58 Fully Supports 58 C2 S# +# mins 58 Q3 Profit Climbs 58 Hydraulic Equipment 58 nieuw 58 Proc Am Soc 58 Mg Usa 58 Hold Fourth Quarter 58 DJ DGAP DD 58 SWOT Analysis http:/www.companiesandmarkets.com aJEH MacDonald 58 Cardiovascular Monitoring 58 5q MDS 58 Buy Stake 58 PRN1 58 Expands Reach 58 并 58 Awarded Contract Extension 58 PIG VIRUS THEY SHOULD 58 Aligns 58 partire dal 58 Announces Additions 58 Announces Formation 58 2Q Net Pft 58 Receptor Agonist 57 Ophthalmol 57 Tyrosine Kinase Inhibitor 57 MERGERS ACQ SOURCE 57 Launches 57 Enters Into Long Term 57 ha annunciato oggi che 57 Subgroup Analysis 57 Bulks Up 57 HOLDING AG 57 Acquires Assets 57 Pressekonferenz 57 Q2 Profit Rises 57 Receives Prestigious 57 Slows Progression 57 Carrefour Crédit Agricole 57 Files Voluntary 57 bis zum 57 Reaches Pact 57 FoodBizIntel 57 Enters Into Collaboration 57 Becomes Newest 57 Extends Offer 57 Join Forces 57 Reports Profitable 57 Oral Formulation 57 Other OTC MNDP 57 Magazine Recognizes 57 Neulasta R 57 Finalizes 57 Revitalizes 57 Genentech Wyeth Pharmaceuticals 57 Angiotensin Converting Enzyme 57 의 는 57 DAY PATTERN FOR 57 PRICE GREAT DISCOUNT FREE 57 Reinvents 57 Flasks Funnels Measuring Cylinders 57 Opts 57 Selects Siemens PLM 57 Announces Launch 57 Selects Camstar 57 Introduces Unique 57 Finalizes Merger 57 PHARM 57 Reports Receipt 57 Issues Voluntary Recall 57 Receives Notice From 57 Announces Cancellation 57 Solteq Oyj 57 Mergers Acquisitions Takeovers 57 Subsidiary Signs 57 Recieves 57 Stockholders Approve Merger Agreement 57 Extends Deadline 57 Outlines Plans 57 Commences Tender Offer 57 Extends Sponsorship 57 Unveil Latest 57 Hits Milestone 57 Launches Redesigned Website 57 CORPORATION AND 57 die Verivox GmbH sondern 57 Posaconazole 57 ® lenalidomide 57 Extends Expiration Date 57 News Unternehmensnachrichten DGAP 57 NOT PACK ITEMS PURCHASED 57 Receives Commitment 57 Ramps Up Production 57 Announces Addition 57 Completes Recapitalization 57 Unveils 57 Accelerates 57 Provides Shareholder 57 Doubles Size 57 La empresa 57 Completes Acquisitions 57 MARKETING AGREEMENTS PRODUCT SOURCE 57 Strengthens 57 미국 의 57 Elevates 57 AND RELATED MATERIALS THAT 57 分析 57 PLC Director PDMR 57 Relapsed Refractory 57 AMCG DEST FISH HUDV 57 JDEMALINE@ENQUIRER.COM 57 Johnson Controls Lear 57 ALN HPN 57 COVER YOUR BODY 57 Technol 57 Files Annual Report 57 Acquire Majority 57 #.# ohne Zeitinformationen 57 Expands Availability 57 är ett 57 Sees Steady 57 의 57 J Am Acad 57 übernimmt 57 Announce Formation 57 ACQUIRES 57 Q3 Profit Soars 57 'S SHAREHOLDERS ARE 57 annonce le 57 Divests 57 EXTRA ® STARBURST 57 ja myoja@joongang.co.kr 57 Opens Door 57 Peginterferon alfa 2b 57 一个 的 57 Obtains Patent 57 Releases Latest 57 Well Positioned 57 Receives Authorization 57 Central Venous Catheters 57 Previously Untreated 57 Unifies 57 Commends 57 Shrs Up 57 am Donnerstag 57 PRAXAIR 57 FOR ANY INVESTMENT OR 57 Forms Joint Venture 57 의 에 57 Metered Dose Inhaler Devices 57 THE VARIOUS TERMS 57 sapropterin dihydrochloride 57 maakt 57 Focus RS WRC +# 57 internationalen 57 RIGHT TO WITHDRAW ANY 57 MEDICAL DEVICES 57 Expand Capacity 57 PRN 57 Gains Ground 57 OR REVISE ANY FORWARD 57 Has Received 57 Subsidiary Enters Into 57 Am J Obstet 57 Posts Lower 57 FRANCISCOCA 57 Drug Eluting Stent System 57 der Autor 57 CONTINUES UP 57 REPLACING 57 Acquires Remaining 57 ANGELESCA 57 Exec Joins 57 Earns Highest 57 Announces Signing 57 # BAROSSA TK INVESTOR 57 Daytradersdigest.com 57 Announces Expansion 57 annuncia la 57 Peginterferon 57 Nasdaq LTXX 57 H.B. Fuller 57 Q3 Profit Rises 57 Forges Partnership 57 Signs Memorandum 57 Subsidiary Wins 57 Introduces 57 PRN9 57 Enters Negotiations 57 PRESS RELEASE #.#.# [003] 57 Serostim ® 57 Announces Acquisition 57 Completes Financing 57 Fourth Consecutive Year 57 Finalizes Joint Venture 57 Für den Zugang zu 57 Rolls Out 57 Multimillion Dollar 57 Bolsters 57 Signs Joint Venture 56 developing Bicifadine serotonin 56 Subsidiary Purchases 56 hat heute die 56 Announcement Regarding 56 Certifies 56 Acquires 56 Scand J 56 Merges 56 Vidaza R